← SynDRA
WAY-208466
SynDRA canonical compound SYN1964314 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | DRD2 | HTR2A | HTR2C | HTR6 | HTR7 |
|---|
| Mechanism of action | serotonin receptor agonist |
|---|
All known targets
- DRD2
- HTR2A
- HTR2C
- HTR6
- HTR7
Mechanisms of action (all sources)
- serotonin receptor agonist
- HTR7 INHIBITOR
- DRD2 INHIBITOR
- HTR2A INHIBITOR
- HTR6 INHIBITOR
- HTR2C INHIBITOR
Cross-references
Synonyms
- UNII-0AXW9ALG9W
- 0AXW9ALG9W
- CHEMBL571858
- SCHEMBL3892710
- GTPL8429
- BDBM50300828
- ZINC38542752
- NCGC00370934-02
- WAY-208466 dihydrochloride, >
- 3-((3-Fluorophenyl)sulfonyl)-N,N-dimethyl-1H-pyrrolo(2,3-b)pyridine-1-ethanamine
- 2-(3-(3-fluorophenylsulfonyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)-N,N-dimethylethanamine
- 1H-Pyrrolo(2,3-b)pyridine-1-ethanamine, 3-((3-fluorophenyl)sulfonyl)-N,N-dimethyl-
- 2-[3-(3-fluorophenyl)sulfonylpyrrolo[2,3-b]pyridin-1-yl]-N,N-dimethylethanamine
Look up WAY-208466 in the interactive SynDRA portal →